Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Gentronix
Gentronix
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Gentronix's transgenic rodent mutation workflow accommodated with new lab
This continued growth follows a successful 2300 sqft expansion in 2021 to increase capacity of genetic, ocular, and skin toxicology testing in 2021
Finance
Gentronix adds capacity and services through laboratory expansion
The business has added a further 2,300 sqft to its footprint at Alderley Park in Cheshire
Finance
Gentronix expands dermal toxicology services
The addition of phototoxicity services, planned for Q2 2021, will enable the assessment of whether materials have adverse toxicity profiles after UV light activation
Regulatory
Gentronix expands sales teams in US and Europe
Appoints Dorothy Zelent and Simon Johns
Manufacturing
Gentronix signs genotoxicity assays agreement with GSK
Gentronix to provide GreenScreen HC and BlueScreen HC genotoxicity assays to GlaxoSmithKline (GSK).
Subscribe now